Detalhe da pesquisa
1.
High-resolution pediatric reference intervals for 15 biochemical analytes described using fractional polynomials.
Clin Chem Lab Med
; 59(7): 1267-1278, 2021 06 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-33565284
2.
Patterns of Prior and Subsequent Neoplasms in Children and Adolescents With Soft Tissue Sarcomas.
J Pediatr Hematol Oncol
; 42(5): e265-e270, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32576783
3.
Next-generation reference intervals for pediatric hematology.
Clin Chem Lab Med
; 57(10): 1595-1607, 2019 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31005947
4.
Hematopoietic stem cell transplantation in children and young adults with secondary myelodysplastic syndrome and acute myelogenous leukemia after aplastic anemia.
Biol Blood Marrow Transplant
; 20(3): 425-9, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24316460
5.
Comparison of horse and rabbit antithymocyte globulin in immunosuppressive therapy for refractory cytopenia of childhood.
Haematologica
; 99(4): 656-63, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24162791
6.
Aberrant DNA methylation characterizes juvenile myelomonocytic leukemia with poor outcome.
Blood
; 117(18): 4871-80, 2011 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21406719
7.
International Consensus Definition of DNA Methylation Subgroups in Juvenile Myelomonocytic Leukemia.
Clin Cancer Res
; 27(1): 158-168, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33139265
8.
Response to upfront azacitidine in juvenile myelomonocytic leukemia in the AZA-JMML-001 trial.
Blood Adv
; 5(14): 2901-2908, 2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297046
9.
Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia.
Haematologica
; 92(3): 397-400, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17339190
10.
RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia.
Nat Commun
; 8(1): 2126, 2017 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29259247
11.
CREBBP is a target of epigenetic, but not genetic, modification in juvenile myelomonocytic leukemia.
Clin Epigenetics
; 8: 50, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27158276
12.
Epigenetic silencing of AKAP12 in juvenile myelomonocytic leukemia.
Epigenetics
; 11(2): 110-9, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26891149
13.
RASA4 undergoes DNA hypermethylation in resistant juvenile myelomonocytic leukemia.
Epigenetics
; 9(9): 1252-60, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25147919
14.
Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.
Br J Haematol
; 129(4): 542-9, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15877738
15.
Hematopoietic stem cell transplantation (HSCT) in children with juvenile myelomonocytic leukemia (JMML): results of the EWOG-MDS/EBMT trial.
Blood
; 105(1): 410-9, 2005 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15353481
16.
Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7.
Blood
; 102(6): 1997-2003, 2003 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12763938